Search

everythinglearnresearchcommunity

for

Search:↓

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Hemp seed oil shows promise in treating localized alopecia areata.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Trichoscopy is effective for diagnosing different types of non-scarring hair loss.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

The four main causes of hair loss in children are fungal infections, pulling out hair, autoimmune hair loss, and stress-related hair shedding.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Alopecia areata in elderly people is usually mild and responds well to treatment.

A woman's hair loss led to discovering she had lupus.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.